99 related articles for article (PubMed ID: 10612700)
1. The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala.
Smith DW; Hewson L; Fuller P; Williams AR; Wheeldon A; Rupniak NM
Brain Res; 1999 Nov; 848(1-2):90-5. PubMed ID: 10612700
[TBL] [Abstract][Full Text] [Related]
2. Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs.
Boyce S; Smith D; Carlson E; Hewson L; Rigby M; O'Donnell R; Harrison T; Rupniak NM
Neuropharmacology; 2001 Jul; 41(1):130-7. PubMed ID: 11445193
[TBL] [Abstract][Full Text] [Related]
3. Investigating the effect of bilateral amygdala lesions on fear conditioning and social interaction in the male Mongolian gerbil.
Woolley ML; Haman M; Higgins GA; Ballard TM
Brain Res; 2006 Mar; 1078(1):151-8. PubMed ID: 16494851
[TBL] [Abstract][Full Text] [Related]
4. The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils.
Rupniak NM; Webb JK; Fisher A; Smith D; Boyce S
Neuropharmacology; 2003 Mar; 44(4):516-23. PubMed ID: 12646288
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of substance P-induced defensive behavior via neurokinin-1 receptor antagonism in the central and medial but not basolateral nuclei of the amygdala in male Wistar rats.
Bassi GS; Carvalho MC; Almada RC; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():146-154. PubMed ID: 28390968
[TBL] [Abstract][Full Text] [Related]
6. C-FOS expression in the rat brain in response to substance P and neurokinin B.
Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
[TBL] [Abstract][Full Text] [Related]
7. Distinct mechanism for antidepressant activity by blockade of central substance P receptors.
Kramer MS; Cutler N; Feighner J; Shrivastava R; Carman J; Sramek JJ; Reines SA; Liu G; Snavely D; Wyatt-Knowles E; Hale JJ; Mills SG; MacCoss M; Swain CJ; Harrison T; Hill RG; Hefti F; Scolnick EM; Cascieri MA; Chicchi GG; Sadowski S; Williams AR; Hewson L; Smith D; Carlson EJ; Hargreaves RJ; Rupniak NM
Science; 1998 Sep; 281(5383):1640-5. PubMed ID: 9733503
[TBL] [Abstract][Full Text] [Related]
8. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
[TBL] [Abstract][Full Text] [Related]
9. Role of tachykinin NK(1) and NK(2) receptors in colonic sensitivity and stress-induced defecation in gerbils.
Kakol-Palm D; Brusberg M; Sand E; Larsson H; Martinez V; Johansson A; von Mentzer B; Påhlman I; Lindström E
Eur J Pharmacol; 2008 Mar; 582(1-3):123-31. PubMed ID: 18234189
[TBL] [Abstract][Full Text] [Related]
10. Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats.
Ebner K; Rupniak NM; Saria A; Singewald N
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4280-5. PubMed ID: 15024126
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
[TBL] [Abstract][Full Text] [Related]
12. Medial amygdaloid suppression of predatory attack behavior in the cat: I Role of a substance P pathway from the medial amygdala to the medial hypothalamus.
Han Y; Shaikh MB; Siegel A
Brain Res; 1996 Apr; 716(1-2):59-71. PubMed ID: 8738221
[TBL] [Abstract][Full Text] [Related]
13. Elevated substance P (NK-1) receptor immunoreactivity in the cerebellum of seizure prone gerbil.
Kim DS; Yoo KY; Hwang IK; Jung JY; Won MH; Seo JH; Kang TC
Neuropeptides; 2005 Feb; 39(1):9-14. PubMed ID: 15627495
[TBL] [Abstract][Full Text] [Related]
14. Positive reinforcing effects of substance P in the rat central nucleus of amygdala.
Kertes E; László K; Berta B; Lénárd L
Behav Brain Res; 2009 Dec; 205(1):307-10. PubMed ID: 19555724
[TBL] [Abstract][Full Text] [Related]
15. [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.
Griffante C; Carletti R; Andreetta F; Corsi M
Br J Pharmacol; 2006 May; 148(1):39-45. PubMed ID: 16501582
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary investigation in schizophrenia.
Weidenhofer J; Yip J; Zavitsanou K; Huang XF; Chahl LA; Tooney PA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1313-21. PubMed ID: 16815618
[TBL] [Abstract][Full Text] [Related]
17. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Vicente MA; Zangrossi H
Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
[TBL] [Abstract][Full Text] [Related]
18. Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans.
Wong BJ; Minson CT
J Physiol; 2006 Dec; 577(Pt 3):1043-51. PubMed ID: 17023511
[TBL] [Abstract][Full Text] [Related]
19. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Nordquist RE; Durkin S; Jacquet A; Spooren W
Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
[TBL] [Abstract][Full Text] [Related]
20. Do substance P and the NK1 receptor have a role in depression and anxiety?
McLean S
Curr Pharm Des; 2005; 11(12):1529-47. PubMed ID: 15892660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
